Genzyme News
Most Popular Genzyme Story
Alex Denner - The 25 most influential people in biopharma today
Good cop, bad cop Alex DennerHedge fund operator Carl Icahn may have received most of the credit, and certainly the lion's share of the cash, created by his high-profile biotech raiding parties. But Read more...
Latest Headlines
- February 8, 2012
- February 7, 2012
- February 6, 2012
- February 1, 2012
- November 15, 2011
- November 8, 2011
- November 7, 2011
- November 2, 2011
- September 6, 2011
- September 2, 2011
- July 11, 2011
- May 10, 2011
- April 27, 2011
- April 5, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
